SASH3
Basic information
Region (hg38): X:129779949-129795201
Previous symbols: [ "CXorf9" ]
Links
Phenotypes
GenCC
Source:
- immunodeficiency 102 (Strong), mode of inheritance: XL
- combined immunodeficiency, X-linked (Strong), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 102 | XL | Allergy/Immunology/Infectious | The condition can involve immunodeficiencies as well as immune dysregulation, and prophylaxis and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious; Hematologic | 33876203; 35464398 |
ClinVar
This is a list of variants' phenotypes submitted to
- Immunodeficiency 102 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SASH3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 29 | 31 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 1 | 0 | 30 | 3 | 3 |
Variants in SASH3
This is a list of pathogenic ClinVar variants found in the SASH3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-129788035-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
X-129788059-C-A | not specified | Uncertain significance (Oct 12, 2024) | ||
X-129788442-T-C | Likely benign (Jan 01, 2023) | |||
X-129788529-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
X-129788554-G-A | not specified | Uncertain significance (Nov 09, 2022) | ||
X-129790968-C-G | Immunodeficiency 102 | Uncertain significance (-) | ||
X-129791019-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
X-129791039-G-A | not specified | Uncertain significance (Oct 07, 2024) | ||
X-129791067-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
X-129791084-G-A | Immunodeficiency | Uncertain significance (Feb 02, 2022) | ||
X-129791180-T-G | not specified | Benign (Jan 24, 2024) | ||
X-129792351-C-T | not specified | Uncertain significance (Sep 28, 2022) | ||
X-129792369-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
X-129792385-C-A | not specified | Uncertain significance (Mar 19, 2024) | ||
X-129792390-C-T | Immunodeficiency 102 | Pathogenic (May 31, 2022) | ||
X-129792415-G-A | not specified | Uncertain significance (Jun 18, 2024) | ||
X-129792432-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
X-129792451-A-C | Uncertain significance (Apr 26, 2024) | |||
X-129792463-C-T | not specified | Uncertain significance (Nov 13, 2024) | ||
X-129792630-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
X-129792738-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
X-129792744-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
X-129792747-G-C | not specified | Uncertain significance (May 26, 2023) | ||
X-129792765-C-T | Benign (Jul 31, 2018) | |||
X-129792766-G-A | not specified | Uncertain significance (Jan 29, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SASH3 | protein_coding | protein_coding | ENST00000356892 | 8 | 15223 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.385 | 0.613 | 125715 | 1 | 2 | 125718 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.85 | 98 | 165 | 0.595 | 0.0000138 | 2483 |
Missense in Polyphen | 17 | 59.636 | 0.28506 | 917 | ||
Synonymous | -1.30 | 88 | 73.8 | 1.19 | 0.00000660 | 773 |
Loss of Function | 2.65 | 3 | 13.5 | 0.222 | 0.00000124 | 192 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000152 | 0.0000993 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000625 | 0.0000462 |
European (Non-Finnish) | 0.0000122 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a signaling adapter protein in lymphocytes. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.263
Intolerance Scores
- loftool
- 0.0772
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24.19
Haploinsufficiency Scores
- pHI
- 0.359
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.603
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.227
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sash3
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- positive regulation of immunoglobulin production;positive regulation of T cell cytokine production;positive regulation of adaptive immune response;positive regulation of B cell proliferation;positive regulation of interferon-gamma production;positive regulation of interleukin-10 production;positive regulation of interleukin-2 production;positive regulation of interleukin-4 production;positive regulation of tumor necrosis factor production;positive regulation of T cell proliferation;positive regulation of CD4-positive, alpha-beta T cell differentiation;positive regulation of organ growth;homeostasis of number of cells within a tissue
- Cellular component
- nucleus;cytoplasm
- Molecular function